lp
escherichia
coli
purchas
st
loui
mo
usa
rabbit
mous
antibodi
procur
santa
cruz
biotechnolog
delawar
ca
usa
rabbit
mapk
mapk
protein
kinas
sapk
jnk
horseradish
peroxidas
hrp
secondari
antibodi
goat
igg
hors
igg
antibodi
purchas
cell
signal
technolog
danver
usa
kit
purchas
invitrogen
eugen
usa
angii
immunosorb
assay
elisa
kit
came
kamiya
biomed
seattl
wa
usa
ma
receptor
blocker
obtain
abbiotech
san
diego
ca
usa
specif
inhibitor
mapk
specif
inhibitor
specif
inhibitor
jnk
purchas
santa
cruz
biotechnolog
delawar
ca
usa
rat
weigh
g
obtain
depart
laboratori
anim
scienc
fudan
univers
shanghai
china
anim
handl
accord
protocol
approv
ethic
committe
anim
research
colleg
medicin
shanghai
jiaotong
univers
shanghai
china
isol
cultur
pulmonari
microvascular
endotheli
cell
pmvec
perform
describ
briefli
rat
euthan
intraperiton
inject
pentobarbit
sodium
thoracotomi
perform
lung
circulatori
system
perfus
inject
ml
phosphat
buffer
salin
pb
via
right
ventricl
lung
remov
wash
ml
dulbecco
modifi
eagl
medium
dmem
st
loui
mo
usa
pleura
care
cut
away
discard
section
mm
cut
outer
edg
remain
lung
tissu
trim
small
piec
lung
tissu
piec
insert
glass
pellet
costar
cambridg
rins
endotheli
cell
medium
sciencel
research
carlsbad
ca
usa
supplement
fetal
calf
serum
uml
penicillinstreptomycin
gml
amphotericin
b
glass
pellet
incub
humidifi
air
h
cultur
media
replac
everi
day
cell
confluenc
harvest
treat
ethylenediaminetetraacet
acid
edta
gibco
grand
island
ny
usa
subcultur
ratio
cobbleston
morpholog
immunostain
rabbit
factor
viii
boster
wuhan
china
fluorescein
isothiocyan
fitc
simplicifolia
isolectin
bsi
santa
cruz
delawar
ca
usa
use
identifi
endotheli
cell
third
fifth
cell
passag
use
follow
experi
total
rna
extract
rat
pmvec
revers
transcrib
cdna
use
revers
transcriptas
takara
bio
japan
cdna
use
amplifi
code
sequenc
follow
primer
forward
revers
cgggatccttagaatgaagtttgagc
three
shrna
sequenc
target
rat
code
region
homolog
nt
mrna
respect
design
small
interf
rna
sirna
invalid
rna
interfer
rnai
sequenc
use
neg
control
correspond
oligonucleotid
templat
shrna
chemic
synthes
pcr
product
purifi
ligat
lentivir
cdna
vector
synthes
shrna
system
bioscienc
ca
usa
ligat
mixtur
transform
compet
e
coli
strain
result
plasmid
confirm
sequenc
accord
manufactur
instruct
vector
carri
shrna
lentiviru
packag
plasmid
produc
cell
use
lipofectamin
invitrogen
carlsbad
ca
usa
supernat
collect
h
later
total
rna
protein
extract
determin
mrna
protein
select
recombin
shrna
lentiviru
suffici
sirna
viral
titer
evalu
gradient
dilut
recombin
lentivirus
name
one
day
seed
pmvec
cell
infect
dilut
multipl
infect
moi
endotheli
cell
medium
refresh
h
later
infect
effici
assess
fluoresc
microscopi
h
infect
one
hundr
microlit
pmvec
normal
seed
plate
cellswel
incub
dmem
h
pmvec
whether
normal
infect
pretreat
nm
h
stimul
mgml
lp
h
follow
normal
cell
pb
untreat
control
normal
cell
treat
without
lp
normal
cell
treat
lp
lp
normal
cell
treat
also
lp
lp
cell
infect
empti
control
viru
receiv
lp
lp
cell
infect
rnai
neg
control
nc
receiv
lp
lp
cell
infect
receiv
lp
lp
cell
infect
receiv
lp
lp
cell
infect
receiv
prior
lp
lp
experi
use
specif
mapk
inhibitor
normal
cell
cell
infect
either
hour
exposur
lp
apoptosi
determin
use
annexin
apoptosi
detect
kit
bd
franklin
lake
nj
usa
accord
manufactur
protocol
brief
cell
harvest
wash
time
pb
centrifug
g
min
resuspend
bind
buffer
hepesnaoh
nacl
mm
ph
final
concentr
cellsml
incub
annexin
min
propidium
iodid
min
room
temperatur
cell
suspens
subject
flow
cytometri
facscalibur
bd
franklin
lake
nj
usa
detect
excit
wavelength
nm
data
analyz
use
cellquest
pro
softwar
bd
franklin
lake
nj
usa
cultur
supernat
group
collect
frozen
angii
concentr
supernat
assay
sandwich
elisa
briefli
plate
coat
monoclon
antibodi
specif
angii
suppli
elisa
kit
elisa
perform
accord
manufactur
instruct
final
absorb
nm
measur
use
reader
laboratori
hercul
ca
usa
concentr
extrapol
standard
curv
obtain
plate
total
protein
extract
cell
use
mammalian
protein
extract
reagent
pierc
il
usa
protein
concentr
determin
bicinchonin
acid
protein
assay
kit
pierc
usa
equal
amount
protein
run
gel
transfer
onto
nitrocellulos
membran
membran
block
skim
milk
salin
mm
tri
mm
nacl
tween
tbst
room
temperatur
h
blot
probe
primari
antibodi
rat
ace
sapkjnk
mapk
phosphoryl
actin
wash
tbst
blot
incub
secondari
igg
wash
tbst
time
membran
develop
chemiluminesc
ecl
detect
kit
imag
film
beta
actin
use
endogen
refer
normal
data
present
mean
standard
deviat
sd
statist
analys
perform
prism
softwar
packag
graphpad
san
diego
ca
usa
data
analyz
use
anova
test
multipl
comparison
less
accept
statist
signific
rate
apoptosi
pmvec
lp
group
expos
lp
h
significantli
higher
pb
control
group
p
fig
cell
infect
receiv
lp
lp
group
rate
apoptosi
p
significantli
lower
pmvec
infect
treat
lp
lp
group
p
normal
pmvec
stimul
lp
apoptosi
rate
given
pretreat
lp
group
significantli
higher
cell
treat
lp
lp
p
fig
howev
apoptosi
rate
cell
infect
receiv
pretreat
prior
lp
lp
group
significantli
lower
lp
group
p
although
signific
differ
lp
group
lp
group
level
supernat
cultur
pmvec
expos
lp
h
significantli
higher
compar
control
group
fig
secret
significantli
inhibit
overexpress
promot
knockdown
pmvec
expos
lp
pretreat
caus
signific
increas
secret
markedli
attenu
overexpress
fig
howev
signific
differ
lp
cell
level
cytokin
supernat
result
indic
suppress
inflammatori
respons
pmvec
antagonist
effect
prevent
protect
effect
angii
level
supernat
lp
group
ngml
significantli
higher
pb
control
group
ngml
p
level
lp
group
slightli
higher
ngml
pb
group
ngml
p
cell
infect
receiv
lp
lp
group
angii
secret
ngml
significantli
less
normal
cell
receiv
lp
lp
group
ngml
angii
level
significantli
higher
pmvec
infect
treat
lp
lp
group
ngml
compar
lp
group
p
contrast
level
pmvec
infect
receiv
lp
lp
group
ngml
p
significantli
higher
lp
group
ngml
also
lp
group
ngml
p
fig
normal
pmvec
expos
lp
angii
level
pretreat
lp
group
ngml
significantli
higher
cell
treat
lp
ngml
p
angii
level
cell
infect
receiv
pretreat
prior
lp
lp
group
ngml
significantli
lower
lp
group
ngml
p
howev
level
normal
pmvec
treat
lp
lp
group
ngml
slightli
less
level
lp
group
p
lp
group
ngml
slightli
higher
p
fig
rel
normal
pmvec
pb
control
group
stimul
lp
h
lp
group
ace
level
higher
level
lower
therefor
ratio
significantli
lower
fig
howev
cell
infect
receiv
lp
lp
group
ratio
compar
control
group
p
contrast
cell
infect
receiv
lp
lp
group
ratio
ratio
lower
lp
group
compar
aceactin
level
lp
group
respect
significantli
lower
normal
pmvec
treat
prior
lp
lp
group
p
ratio
also
notabl
lower
lp
group
compar
control
group
significantli
differ
lp
group
fig
addit
compar
aceactin
level
normal
cell
treat
lp
lp
group
respect
cell
infect
treat
lp
lp
group
significantli
higher
p
aceactin
similar
p
result
ratio
much
higher
lp
group
western
blot
result
show
normal
pmvec
incub
lp
h
lp
group
phosphoryl
level
sapkjnk
significantli
higher
compar
untreat
control
group
fig
compar
lp
group
pmvec
transduc
incub
lp
lp
group
lower
level
phosphoryl
sapkjnk
level
phosphoryl
markedli
less
contrast
compar
lp
group
pmvec
transduc
incub
lp
lp
group
significantli
higher
phosphoryl
level
level
phosphoryl
sapkjnk
similar
pretreat
cell
lp
group
associ
significantli
higher
phosphoryl
level
three
mapk
pathway
rel
cell
lp
group
wherea
compar
lp
group
level
phosphoryl
sapkjnk
phosphoryl
lp
group
markedli
lower
p
obviou
differ
level
lp
lp
group
p
fig
f
furthermor
compar
lp
group
phosphoryl
level
slightli
less
lp
group
p
significantli
higher
lp
group
phosphoryl
level
lp
group
still
enhanc
lp
group
p
addit
level
phosphoryl
lp
group
approxim
lp
group
p
level
phosphoryl
sapkjnk
significantli
higher
p
phosphoryl
express
examin
western
blot
fig
lp
stimul
result
significantli
increas
level
phosphoryl
decreas
level
express
normal
pmvec
cell
infect
stimul
lp
lp
group
phosphoryl
level
significantli
lower
express
level
significantli
higher
pmvec
stimul
lp
contrast
compar
lp
group
pmvec
transduc
stimul
lp
lp
group
significantli
higher
phosphoryl
level
lower
express
level
phosphoryl
level
significantli
higher
level
lower
cell
stimul
lp
pretreat
lp
group
compar
lp
group
phosphoryl
level
lp
group
significantli
higher
lp
group
significantli
differ
lp
lp
group
level
lp
group
approxim
similar
lp
group
significantli
increas
compar
lp
group
clarifi
whether
inhibit
mapk
activ
influenc
effect
antagonist
pmvec
apoptosi
cell
mapk
signal
pathway
specif
inhibitor
lp
stimul
fig
compar
apoptosi
level
lp
group
pretreat
without
pretreat
significantli
inhibit
apoptosi
normal
transduc
pmvec
apoptosi
level
lp
lp
lp
lp
group
respect
p
apoptosi
cell
infect
stimul
lp
significantli
increas
pretreat
lp
group
compar
lp
lp
group
respect
p
apoptosi
level
cell
infect
pretreat
prior
lp
stimul
significantli
higher
lp
group
lp
lp
group
respect
compar
lp
group
p
affect
apoptosi
cell
infect
normal
cell
pretreat
lp
stimul
lp
lp
lp
lp
lp
group
compar
lp
group
p
cell
infect
stimul
lp
lp
group
pretreat
specif
mapk
signal
inhibitor
affect
secret
fig
contrast
mapk
signal
inhibitor
especi
pretreat
pmvec
transduc
stimul
lp
lp
group
significantli
suppress
cytokin
secret
fig
pmvec
expos
lp
pretreat
significantli
increas
slightli
reduc
significantli
attenu
secret
fig
addit
affect
secret
cell
infect
pretreat
prior
lp
stimul
lp
group
secret
lp
group
significantli
inhibit
fig
present
studi
investig
effect
overexpress
injuri
pmvec
found
overexpress
attenu
apoptosi
secret
caus
lp
stimul
delet
ma
receptor
inhibit
exhibit
almost
similar
deterior
effect
damag
cytokin
secret
block
overexpress
therefor
protect
effect
overexpress
apoptosi
inflammatori
respons
may
regul
ma
receptor
fact
act
ace
regul
product
angii
addit
infect
caus
downregul
express
lung
treatment
protect
mous
lung
sever
acut
also
note
express
lung
tissu
downregul
mous
ard
model
induc
acid
aspir
endotoxin
periton
studi
loss
express
mutant
mice
result
sever
lung
injuri
enhanc
vascular
permeabl
increas
lung
edema
worsen
lung
function
found
angii
level
cell
supernat
higher
lp
stimul
lp
stimul
addit
overexpress
revers
imbal
significantli
reduc
angii
increas
ang
level
thu
reduc
apoptosi
inflamm
contrast
express
aggrav
imbal
markedli
increas
angii
decreas
ang
level
promot
apoptosi
inflammatori
respons
caus
lp
exposur
ma
receptor
blocker
effect
abolish
protect
effect
transgenesi
imbal
affect
treatment
ma
receptor
blocker
lp
stimul
also
significantli
increas
angii
obviou
influenc
ang
level
may
ascrib
signific
suppress
express
ma
receptor
blocker
therefor
protect
effect
pmvec
injuri
may
via
regul
ma
receptor
fact
mani
report
suggest
angii
exert
effect
induc
releas
cytokin
chemokin
adhes
molecul
growth
factor
reactiv
oxygen
speci
angii
also
significantli
induc
apoptosi
pulmonari
endotheli
cell
receptor
lead
damag
epitheli
barrier
function
increas
hand
bind
specif
receptor
ma
counteract
angii
function
ie
vasodilatori
effect
overexpress
ang
prevent
lung
injuri
blockad
ma
receptor
abolish
benefici
effect
ang
pulmonari
ang
attenu
acid
lung
injuri
barrier
failur
pmvec
effect
block
ma
receptor
moreov
experiment
result
also
indic
unbalanc
angiiang
associ
develop
ard
chang
angiiang
close
relat
ratio
bronchoalveolar
lavag
fluid
balf
ventil
anim
expos
lp
activ
reduc
wherea
ace
activ
enhanc
chang
accord
enhanc
balf
level
angii
reduc
level
ang
imbal
local
lung
tissu
accompani
chang
angiiang
thu
believ
imbal
ma
receptor
mediat
lung
injuri
regul
ra
homeostasi
may
improv
lung
injuri
activ
mapk
pathway
key
role
progress
acut
lung
injuri
fulli
elucid
pmvec
exposur
present
studi
found
overexpress
significantli
block
activ
jnk
pathway
strikingli
prevent
administr
ma
receptor
blocker
suggest
protect
apoptosi
pmvec
inflamm
perhap
ma
pathway
modul
jnk
phosphoryl
hand
enhanc
erk
phosphoryl
influenc
jnk
phosphoryl
wherea
increas
erk
phosphoryl
affect
overexpress
cell
pretreat
ma
receptor
blocker
result
suggest
inhibit
aggrav
pmvec
apoptosi
inflamm
mainli
pathway
enhanc
erk
phosphoryl
fact
activ
mapk
erk
associ
increas
permeabl
pulmonari
endotheli
cell
prolifer
surviv
lung
endotheli
cell
maintain
endotheli
monolay
integr
may
way
activ
bleomycin
induc
cell
apoptosi
jnk
phosphoryl
pathway
alveolar
epitheli
cell
aec
addit
regul
balanc
angiiang
inhibit
apoptosi
alveolar
epitheli
cell
blockad
jnk
also
perform
addit
experi
determin
whether
ma
axi
prevent
inflammatori
respons
apoptosi
rat
pmvec
via
inhibit
jnk
phosphoryl
found
protect
effect
overexpress
apoptosi
enhanc
jnk
inhibitor
deterior
erk
inhibit
jnk
inhibitor
markedli
reduc
apoptosi
cytokin
secret
pmvec
delet
pretreat
ma
receptor
antagonist
ma
receptor
antagonist
abolish
protect
effect
aggrav
erk
inhibitor
revers
jnk
inhibit
therefor
data
suggest
ma
may
protect
effect
apoptosi
inflamm
pmvec
mainli
inhibit
jnk
pathway
present
studi
found
overexpress
significantli
inhibit
activ
degrad
protein
strikingli
revers
ma
receptor
antagonist
addit
downregul
pretreat
enhanc
phosphoryl
degrad
protein
suggest
pathway
also
import
prevent
ma
pmvec
apoptosi
inflamm
fact
bind
cytoplasm
dissoci
activ
transloc
nucleu
upregul
transcript
sever
inflammatori
cascad
pivot
intracellular
signal
pathway
involv
apoptosi
inflammatori
respons
activ
central
regul
pulmonari
inflamm
involv
pathogenesi
lung
injuri
associ
activ
mapk
signal
inhibit
erk
protect
lung
injuri
inhibit
pretreat
prevent
lung
fibroblast
apoptot
resist
inhibit
conclus
result
suggest
abnorm
activ
ra
unbalanc
angiiang
level
induc
imbal
express
close
relat
apoptosi
inflamm
pmvec
furthermor
exert
protect
effect
apoptosi
inflamm
pmvec
suppress
signal
pathway
find
impli
may
appli
improv
lung
injuri
via
regul
ma
receptor
inhibit
signal
pathway
upregul
ma
axi
inhibit
activ
may
effect
therapeut
strategi
ard
clinic
limit
studi
result
address
crosstalk
mapk
signal
pathway
studi
necessari
investig
possibl
crosstalk
among
intracellular
signal
pathway
involv
effect
ang
ma
receptor
pmvec
apoptosi
administr
pmvec
expos
lp
vitro
addit
whether
ang
ma
receptor
lead
prevent
acut
lung
injuri
signal
pathway
vivo
address
lyc
propos
hypothesi
design
experi
wrote
manuscript
cym
carri
immunoassay
zz
perform
flow
cytometri
analysi
lmf
perform
analysi
xy
xch
particip
design
studi
perform
data
analysi
zm
help
edit
manuscript
jw
conceiv
studi
particip
design
coordin
author
read
approv
final
manuscript
